bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) shares crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $109.17 and traded as low as $105.67. bioMérieux shares last traded at $105.67, with a volume of 56 shares trading hands.
bioMérieux Stock Performance
The stock’s 50 day moving average price is $109.17 and its 200-day moving average price is $106.10.
bioMérieux Company Profile
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Recommended Stories
- Five stocks we like better than bioMérieux
- About the Markup Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
- Low PE Growth Stocks: Unlocking Investment Opportunities
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
